BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37358003)

  • 1. Circadian rhythm alterations affecting the pathology of neurodegenerative diseases.
    Canever JB; Queiroz LY; Soares ES; de Avelar NCP; Cimarosti HI
    J Neurochem; 2023 Jun; ():. PubMed ID: 37358003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.
    Maiese K
    Curr Neurovasc Res; 2017; 14(3):299-304. PubMed ID: 28721811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications from proteomic studies investigating circadian rhythm disorder-regulated neurodegenerative disease pathology.
    Liu W; Ma R; Sun C; Xu Y; Liu Y; Hu J; Ma Y; Wang D; Wen D; Yu Y
    Sleep Med Rev; 2023 Aug; 70():101789. PubMed ID: 37253318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases.
    Chen D; Zhang T; Lee TH
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic Spine Pathology in Neurodegenerative Diseases.
    Herms J; Dorostkar MM
    Annu Rev Pathol; 2016 May; 11():221-50. PubMed ID: 26907528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone Methylation Regulation in Neurodegenerative Disorders.
    Basavarajappa BS; Subbanna S
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Neuromolecular Med; 2018 Jun; 20(2):174-204. PubMed ID: 29572723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
    Benatar M; Wuu J; McHutchison C; Postuma RB; Boeve BF; Petersen R; Ross CA; Rosen H; Arias JJ; Fradette S; McDermott MP; Shefner J; Stanislaw C; Abrahams S; Cosentino S; Andersen PM; Finkel RS; Granit V; Grignon AL; Rohrer JD; McMillan CT; Grossman M; Al-Chalabi A; Turner MR;
    Brain; 2022 Mar; 145(1):27-44. PubMed ID: 34677606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoding mitochondrial quality control mechanisms: Identifying treatment targets for enhanced cellular health.
    Wankhede NL; Rajendra Kopalli S; Dhokne MD; Badnag DJ; Chandurkar PA; Mangrulkar SV; Shende PV; Taksande BG; Upaganlawar AB; Umekar MJ; Koppula S; Kale MB
    Mitochondrion; 2024 Jun; 78():101926. PubMed ID: 38944367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proteasome: A key modulator of nervous system function, brain aging, and neurodegenerative disease.
    Davidson K; Pickering AM
    Front Cell Dev Biol; 2023; 11():1124907. PubMed ID: 37123415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal Ganglion Cells and Circadian Rhythms in Alzheimer's Disease, Parkinson's Disease, and Beyond.
    La Morgia C; Ross-Cisneros FN; Sadun AA; Carelli V
    Front Neurol; 2017; 8():162. PubMed ID: 28522986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of glutathione homeostasis in neurodegenerative diseases.
    Johnson WM; Wilson-Delfosse AL; Mieyal JJ
    Nutrients; 2012 Oct; 4(10):1399-440. PubMed ID: 23201762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining circadian disruption in neurodegenerative disorders.
    Colwell CS
    J Clin Invest; 2021 Oct; 131(19):. PubMed ID: 34596047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy.
    Karnati HK; Panigrahi MK; Gutti RK; Greig NH; Tamargo IA
    J Alzheimers Dis; 2015; 48(3):563-80. PubMed ID: 26402105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of Long Non-coding RNAs in the Development of Aging-Related Neurodegenerative Diseases.
    Ni YQ; Xu H; Liu YS
    Front Mol Neurosci; 2022; 15():844193. PubMed ID: 35359573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian rhythms in neurodegenerative disorders.
    Nassan M; Videnovic A
    Nat Rev Neurol; 2022 Jan; 18(1):7-24. PubMed ID: 34759373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian alterations in patients with neurodegenerative diseases: Neuropathological basis of underlying network mechanisms.
    Fifel K; Videnovic A
    Neurobiol Dis; 2020 Oct; 144():105029. PubMed ID: 32736083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegenerative Disease and the NLRP3 Inflammasome.
    Holbrook JA; Jarosz-Griffiths HH; Caseley E; Lara-Reyna S; Poulter JA; Williams-Gray CH; Peckham D; McDermott MF
    Front Pharmacol; 2021; 12():643254. PubMed ID: 33776778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronobiology of Parkinson's disease: Past, present and future.
    Asadpoordezaki Z; Coogan AN; Henley BM
    Eur J Neurosci; 2023 Jan; 57(1):178-200. PubMed ID: 36342744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Review: Quantitative Susceptibility Mapping (QSM) of Brain Iron Profile in Neurodegenerative Diseases.
    Ravanfar P; Loi SM; Syeda WT; Van Rheenen TE; Bush AI; Desmond P; Cropley VL; Lane DJR; Opazo CM; Moffat BA; Velakoulis D; Pantelis C
    Front Neurosci; 2021; 15():618435. PubMed ID: 33679303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.